Concepedia

Author

Stefan Blech

Boehringer Ingelheim (Germany)ORCID

Also Known As

Stefan Blech

9

Publications

941

Citations

6

H-Index

10

Concepts

All Affiliations

Boehringer Ingelheim (Germany)GlaxoSmithKline (United Kingdom)Janssen (Belgium)
SB

About

Stefan Blech is an author at Boehringer Ingelheim (Germany) specializing in drug analysis, analytical chemistry, and toxicology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

21

2

Biochemistry

1

1

21

3

Pharmacology

1

1

21

4

Drug Discovery

1

1

21

5

Mass Spectrometry

1

1

21

Stefan Blech

×

5

Publications

925

Citations

5

H-Index

YearCitations

The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

Stefan Blech, Thomas Ebner, Eva Ludwig-Schwellinger,

Drug Metabolism and Disposition

2007

676

The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans

Stefan Blech, Eva Ludwig-Schwellinger, Eva Ulrike Gräfe-Mody,

Drug Metabolism and Disposition

2010

187

Considerations for Human <scp>ADME</scp> Strategy and Design Paradigm Shift(s) – An Industry White Paper

Graeme Young, Douglas K. Spracklin, Alexander D. James,

Clinical Pharmacology & Therapeutics

2022

26

Best Practices for Metabolite Quantification in Drug Development: Updated Recommendation from The European Bioanalysis Forum

Philip Timmerman, Stefan Blech, Stephen White,

Bioanalysis

2016

21

Resolving the microcosmos of complex samples: UPLC/travelling wave ion mobility separation high resolution mass spectrometry for the analysis of in vivo drug metabolism studies

Stefan Blech, Ralf Laux

International Journal for Ion Mobility Spectrometry

2012

15

Page 1